FTC Monitoring Use Of Clinical Trial Results In Supplement Ads
This article was originally published in The Tan Sheet
Executive Summary
FTC is increasing scrutiny of clinical study results cited in ads for weight-loss supplements
You may also be interested in...
Slap On The Wrist? FTC Puts Out Media Guidance On Weight Loss Ad Claims
A series of actions unveiled by the Federal Trade Commission to combat false advertising claims for weight loss products includes a set of media guidelines to help prevent dissemination of deceptive ads
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands